We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT04566393
Brief Title: Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered Malignancies

First Submitted : September 17, 2020
First Submitted that Met QC Criteria : September 21, 2020
First Posted : September 28, 2020

Last Update Submitted that Met QC Criteria : February 13, 2023
Last Update Posted : February 14, 2023